Therapy Areas
KT Tape introduces KT Recovery+ Wave
23 February 2021 -

KT Tape, a company that deals with drug-free pain relief, has launched its KT Recovery+ Wave, it was reported on Monday.

The company says that the product is a clinically proven and FDA approved wearable device that offers drug-free pain relief for sports injuries, knee pain, arthritis, back pain, carpal tunnel, sprains and more.

The new KT Recovery+ Wave utilises sensation-free electromagnetic pulses called pulsed shortwave therapy to decrease nerve hypersensitivity and relieve pain. It has a guaranteed battery life of 250 hours and is available at an MSRP of USD34.99.

Login
Username:

Password:


Related Headlines

Towne Health to aid healthcare providers, government agencies & community organizations in COVID-19 vaccination across the US

Blue Cross and Blue Shield of Minnesota to scale up speed of COVID-19 vaccinations of at-risk seniors

Ro partners with New York State's Department Of Health to introduce first ever home COVID-19 vaccination plan

Efficacy data of India's domestic COVID-19 vaccine expected to boost public acceptance

Offer from intermediary in UAE for purchase of AstraZeneca's COVID-19 vaccines declined by Czech Republic

ReViral, LianBio Ink Collaboration and License Agreement to Develop and Commercialize Sisunatovir in China

VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19

Guardant360 CDx Liquid Biopsy Granted CE Mark for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

FDA Approves Investigational New Drug for Neuroendocrine Tumors from Molecular Targeting Technologies

Akoya, Johns Hopkins' Collaborative Agreement Supports Pioneering New Approach to Immunotherapy Biomarker Discovery and Validation

Aegea Biotechnologies Inks Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load

VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19

CN Bio Awarded Innovate UK Grant to Develop Single and Multi-organ Models for COVID-19 Research

Applied DNA, Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Feline Veterinary Market

AcuCort granted US trademark protection for ISICORT